Secondary Amenorrhea in a Competitive Runner with Low BMI
A 24-year-old nulligravida competitive distance runner (BMI 17.8, training 70 miles/week) presents with 9 months of amenorrhea after previously regular cycles. She reports stress fractures of the tibia and metatarsal over the past two years. Exam: low body fat, no hirsutism, no galactorrhea. Labs: beta-hCG negative, TSH 1.8 mIU/L, prolactin 12 ng/mL, FSH 4.1 mIU/L, LH 0.8 mIU/L, estradiol 18 pg/mL. Progesterone challenge produces no withdrawal bleed. Pelvic ultrasound shows a thin endometrium and small multifollicular ovaries without dominant follicle. DEXA reveals a Z-score of -2.1 at the lumbar spine. She asks whether she can simply take a combined oral contraceptive and continue training for an upcoming national championship in 10 weeks.
1. Construct the diagnosis and explain the hormonal mechanism linking her training load, energy availability, and bone loss.
Read the worked answer
The picture is functional hypothalamic amenorrhea (FHA) driven by low energy availability (relative energy deficiency in sport, RED-S).
Mechanism: Chronic energy deficit and/or exercise stress raise cortisol and suppress hypothalamic GnRH pulse frequency. Low-frequency GnRH pulses preferentially favor FSH over LH secretion, producing the low LH (0.8), low-normal FSH (4.1), and low estradiol (18) pattern. Absent estrogen removes negative feedback restraint but the dominant lesion is central; the hypoestrogenic state causes endometrial atrophy (no withdrawal bleed) and accelerated bone loss (Z -2.1).
Key discriminators: beta-hCG excluded pregnancy; normal TSH and prolactin exclude thyroid disease and hyperprolactinemia; the low LH:FSH ratio and low estradiol argue against PCOS, which typically shows elevated LH and preserved or high estradiol. Small multifollicular ovaries on ultrasound are consistent with arrested follicular development, not PCOS.
Judgment point: The Z-score of -2.1 in a young woman is clinically significant and mandates addressing the underlying energy deficit, not masking it.
2. Evaluate her request for a combined oral contraceptive as sole management, and outline a prioritized management plan.
Read the worked answer
COC is not adequate sole therapy. A COC provides contraceptive cover and cyclic withdrawal bleeding but does not restore bone accrual reliably and, critically, does not correct the energy deficit that is driving the disorder. There is also concern that COC-induced withdrawal bleeds can falsely reassure the athlete that the hypothalamic axis has recovered. Some data suggest COCs may blunt the bone-anabolic effect of recovered endogenous estrogen, though this is debated; regardless, the primary intervention is energy restoration.
Prioritized plan:
- Increase energy availability - refer to sports medicine/dietitian; target increased caloric intake and/or reduced training volume. This is the evidence-based first-line treatment.
- Counsel on training modification - continuing 70 miles/week through a national championship in 10 weeks is likely incompatible with recovery; discuss graduated reduction and the risk of further stress fractures.
- Bone health - calcium and vitamin D optimization; DEXA follow-up; consider endocrinology input. Bisphosphonates are generally avoided in reproductive-age women planning pregnancy.
- Hormonal therapy - if menses do not return with energy restoration, consider physiologic estrogen (transdermal estradiol with cyclic progestin) rather than a standard COC, with shared decision-making.
- Contraception - address separately; if she needs contraception, a COC or other method can be used, but it should not replace energy restoration.
- Screen for depression/anxiety and disordered eating, which commonly coexist.
The judgment being tested: recognizing that the "easy" pharmacologic answer (COC) does not treat the root cause and could delay bone-protective intervention.